Chinese General Practice ›› 2022, Vol. 25 ›› Issue (24): 3049-3056.DOI: 10.12114/j.issn.1007-9572.2021.02.008
Special Issue: 神经退行性病变最新文章合集; 阿尔茨海默病最新文章合集
• Evidence-based Medicine • Previous Articles Next Articles
Received:
2021-08-22
Revised:
2022-02-26
Published:
2022-08-20
Online:
2022-05-26
Contact:
Qian WU
About author:
通讯作者:
吴茜
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2021.02.008
序号 | 检索策略 |
---|---|
#1 | ((((((((((((Intracranial Thrombosis[Title/Abstract])OR(Lacunar Stroke[Title/Abstract]))OR(Ischemic Event[Title/Abstract]))OR(Brain Thrombosis[Title/Abstract]))OR(Cerebral Thrombus[Title/Abstract]))OR(Intracranial Thrombus[Title/Abstract]))OR(Ischemic Encephalopathies[Title/Abstract]))OR(Lacunar Infarct[Title/Abstract]))OR(Ischemic Attack[Title/Abstract]))OR(Poststroke[Title/Abstract]))OR("Cerebral Infarction"[Mesh]))OR("Brain Ischemia"[Mesh])))) |
#2 | ((((((((Cognitive Impairment[Title/Abstract])OR(Cognitive Deficit[Title/Abstract]))OR(Cognitive Decline[Title/Abstract]))OR(Cognition Disorders[Title/Abstract]))OR(Mental Deterioration[Title/Abstract]))OR(Post-stroke cognitive impairment[Title/Abstract]))OR Cognition Disorders[Title/Abstract]))OR("Cognitive Dysfunction"[Mesh])) |
#3 | (((((Factor[Title/Abstract])OR(Influencing Factor[Title/Abstract]))OR(Risk Factor[Title/Abstract]))OR(Related Factor[Title/Abstract])) |
#4 | #1 AND #2 AND #3 |
Table 1 Strategy for searching cohort studies about influencing factors of cognitive impairment 3 to 6 months after ischemic stroke in PubMed
序号 | 检索策略 |
---|---|
#1 | ((((((((((((Intracranial Thrombosis[Title/Abstract])OR(Lacunar Stroke[Title/Abstract]))OR(Ischemic Event[Title/Abstract]))OR(Brain Thrombosis[Title/Abstract]))OR(Cerebral Thrombus[Title/Abstract]))OR(Intracranial Thrombus[Title/Abstract]))OR(Ischemic Encephalopathies[Title/Abstract]))OR(Lacunar Infarct[Title/Abstract]))OR(Ischemic Attack[Title/Abstract]))OR(Poststroke[Title/Abstract]))OR("Cerebral Infarction"[Mesh]))OR("Brain Ischemia"[Mesh])))) |
#2 | ((((((((Cognitive Impairment[Title/Abstract])OR(Cognitive Deficit[Title/Abstract]))OR(Cognitive Decline[Title/Abstract]))OR(Cognition Disorders[Title/Abstract]))OR(Mental Deterioration[Title/Abstract]))OR(Post-stroke cognitive impairment[Title/Abstract]))OR Cognition Disorders[Title/Abstract]))OR("Cognitive Dysfunction"[Mesh])) |
#3 | (((((Factor[Title/Abstract])OR(Influencing Factor[Title/Abstract]))OR(Risk Factor[Title/Abstract]))OR(Related Factor[Title/Abstract])) |
#4 | #1 AND #2 AND #3 |
第一作者 | 发表年份 | PSCI患者例数 | 卒中后认知功能评估时间 | 影响因素 | 研究对象来源 | NOS总分(分) |
---|---|---|---|---|---|---|
DHARMASAROJA[ | 2020 | 139 | 第3~6个月 | ⑥⑦ | 泰国 | 7 |
LO[ | 2020 | 1 168 | 第3~6个月 | ④ | 国际联盟 | 9 |
LING[ | 2020 | 53 | 第3个月 | ⑧⑨ | 中国 | 8 |
LU[ | 2019 | 113 | 第3个月 | ②③⑦⑨ | 中国 | 8 |
WENG[ | 2019 | 176 | 第3个月 | ①⑧ | 中国 | 8 |
JIA[ | 2020 | 523 | 第3个月 | ①②⑧⑩ | 中国 | 8 |
LIU[ | 2019 | 45 | 第3个月 | ② | 中国 | 8 |
CHI[ | 2019 | 42 | 第3个月 | ②⑦ | 中国 | 8 |
GUO[ | 2018 | 92 | 第6个月 | ⑥ | 中国 | 8 |
SWARDFAGER[ | 2017 | 136 | 第3个月 | ④ | 加拿大 | 8 |
CHANDER[ | 2017 | 217 | 第3~5个月 | ①②⑤ | 新加坡 | 8 |
ZHOU[ | 2004 | 118 | 第3个月 | ①②⑤⑥⑩ | 中国 | 7 |
YU[ | 2013 | 353 | 第3个月 | ① | 韩国 | 8 |
TANG[ | 2006 | 39 | 第3个月 | ②⑤⑧ | 中国 | 7 |
MELLON[ | 2015 | 128 | 第6个月 | ①⑥ | 英国 | 7 |
JACQUIN[ | 2014 | 104 | 第3个月 | ①③④⑤ | 法国 | 8 |
CHAUDHARI[ | 2014 | 46 | 第3~6个月 | ⑧ | 英国 | 8 |
吴纪霞[ | 2018 | 132 | 第6个月 | ①⑨⑩ | 中国 | 8 |
庄献博[ | 2015 | 53 | 第3个月 | ① | 中国 | 8 |
潘广伟[ | 2011 | 20 | 第3个月 | ①⑨ | 中国 | 7 |
陆珍辉[ | 2018 | 34 | 第6个月 | ②⑦⑨ | 中国 | 8 |
李灵真[ | 2011 | 73 | 第3个月 | ③⑥ | 中国 | 7 |
符晓艳[ | 2017 | 159 | 第3个月 | ②⑧ | 中国 | 7 |
李淑恩[ | 2020 | 124 | 第6个月 | ③⑦⑧ | 中国 | 7 |
王延江[ | 2008 | 95 | 第3个月 | ①②⑩ | 中国 | 7 |
戴一帆[ | 2012 | 50 | 第3个月 | ①④ | 中国 | 7 |
樊凡[ | 2018 | 90 | 第3个月 | ① | 中国 | 8 |
Table 2 Basic characteristics and evaluation of methodological quality of included studies
第一作者 | 发表年份 | PSCI患者例数 | 卒中后认知功能评估时间 | 影响因素 | 研究对象来源 | NOS总分(分) |
---|---|---|---|---|---|---|
DHARMASAROJA[ | 2020 | 139 | 第3~6个月 | ⑥⑦ | 泰国 | 7 |
LO[ | 2020 | 1 168 | 第3~6个月 | ④ | 国际联盟 | 9 |
LING[ | 2020 | 53 | 第3个月 | ⑧⑨ | 中国 | 8 |
LU[ | 2019 | 113 | 第3个月 | ②③⑦⑨ | 中国 | 8 |
WENG[ | 2019 | 176 | 第3个月 | ①⑧ | 中国 | 8 |
JIA[ | 2020 | 523 | 第3个月 | ①②⑧⑩ | 中国 | 8 |
LIU[ | 2019 | 45 | 第3个月 | ② | 中国 | 8 |
CHI[ | 2019 | 42 | 第3个月 | ②⑦ | 中国 | 8 |
GUO[ | 2018 | 92 | 第6个月 | ⑥ | 中国 | 8 |
SWARDFAGER[ | 2017 | 136 | 第3个月 | ④ | 加拿大 | 8 |
CHANDER[ | 2017 | 217 | 第3~5个月 | ①②⑤ | 新加坡 | 8 |
ZHOU[ | 2004 | 118 | 第3个月 | ①②⑤⑥⑩ | 中国 | 7 |
YU[ | 2013 | 353 | 第3个月 | ① | 韩国 | 8 |
TANG[ | 2006 | 39 | 第3个月 | ②⑤⑧ | 中国 | 7 |
MELLON[ | 2015 | 128 | 第6个月 | ①⑥ | 英国 | 7 |
JACQUIN[ | 2014 | 104 | 第3个月 | ①③④⑤ | 法国 | 8 |
CHAUDHARI[ | 2014 | 46 | 第3~6个月 | ⑧ | 英国 | 8 |
吴纪霞[ | 2018 | 132 | 第6个月 | ①⑨⑩ | 中国 | 8 |
庄献博[ | 2015 | 53 | 第3个月 | ① | 中国 | 8 |
潘广伟[ | 2011 | 20 | 第3个月 | ①⑨ | 中国 | 7 |
陆珍辉[ | 2018 | 34 | 第6个月 | ②⑦⑨ | 中国 | 8 |
李灵真[ | 2011 | 73 | 第3个月 | ③⑥ | 中国 | 7 |
符晓艳[ | 2017 | 159 | 第3个月 | ②⑧ | 中国 | 7 |
李淑恩[ | 2020 | 124 | 第6个月 | ③⑦⑧ | 中国 | 7 |
王延江[ | 2008 | 95 | 第3个月 | ①②⑩ | 中国 | 7 |
戴一帆[ | 2012 | 50 | 第3个月 | ①④ | 中国 | 7 |
樊凡[ | 2018 | 90 | 第3个月 | ① | 中国 | 8 |
结局指标 | 随机效应模型 | 固定效应模型 | 稳定性 | ||
---|---|---|---|---|---|
OR(95%CI) | P值 | OR(95%CI) | P值 | ||
年龄 | 1.10(1.06,1.14) | <0.000 01 | 1.07(1.06,1.08) | <0.000 01 | 稳定 |
受教育程度 | 0.77(0.71,0.83) | <0.000 01 | 0.82(0.78,0.85) | <0.000 01 | 稳定 |
高血压 | 2.84(1.82,4.45) | <0.000 01 | 2.69(1.90,3.81) | <0.000 01 | 稳定 |
糖尿病 | 2.35(1.59,3.49) | <0.000 1 | 1.95(1.58,2.39) | <0.000 01 | 稳定 |
心房颤动 | 2.22(1.49,3.31) | <0.000 01 | 2.92(1.92,4.45) | <0.000 01 | 稳定 |
卒中史 | 2.68(1.95,3.68) | <0.000 01 | 2.68(1.95,3.68) | <0.000 01 | 稳定 |
Fazakas评分 | 1.96(1.54,2.49) | <0.000 01 | 1.86(1.57,2.21) | <0.000 01 | 稳定 |
入院时NIHSS评分 | 1.44(1.17,1.77) | 0.000 6 | 1.22(1.13,1.31) | <0.000 01 | 稳定 |
高同型半胱氨酸血症 | 1.08(1.02,1.14) | 0.006 | 1.05(1.02,1.07) | 0.000 2 | 稳定 |
饮酒 | 2.85(2.00,4.04) | <0.000 01 | 2.85(2.00,4.04) | <0.000 01 | 稳定 |
Table 3 Sensitivity analysis of Meta-analysis results
结局指标 | 随机效应模型 | 固定效应模型 | 稳定性 | ||
---|---|---|---|---|---|
OR(95%CI) | P值 | OR(95%CI) | P值 | ||
年龄 | 1.10(1.06,1.14) | <0.000 01 | 1.07(1.06,1.08) | <0.000 01 | 稳定 |
受教育程度 | 0.77(0.71,0.83) | <0.000 01 | 0.82(0.78,0.85) | <0.000 01 | 稳定 |
高血压 | 2.84(1.82,4.45) | <0.000 01 | 2.69(1.90,3.81) | <0.000 01 | 稳定 |
糖尿病 | 2.35(1.59,3.49) | <0.000 1 | 1.95(1.58,2.39) | <0.000 01 | 稳定 |
心房颤动 | 2.22(1.49,3.31) | <0.000 01 | 2.92(1.92,4.45) | <0.000 01 | 稳定 |
卒中史 | 2.68(1.95,3.68) | <0.000 01 | 2.68(1.95,3.68) | <0.000 01 | 稳定 |
Fazakas评分 | 1.96(1.54,2.49) | <0.000 01 | 1.86(1.57,2.21) | <0.000 01 | 稳定 |
入院时NIHSS评分 | 1.44(1.17,1.77) | 0.000 6 | 1.22(1.13,1.31) | <0.000 01 | 稳定 |
高同型半胱氨酸血症 | 1.08(1.02,1.14) | 0.006 | 1.05(1.02,1.07) | 0.000 2 | 稳定 |
饮酒 | 2.85(2.00,4.04) | <0.000 01 | 2.85(2.00,4.04) | <0.000 01 | 稳定 |
Figure 12 Funnel plot assessing the potential risk of bias in studies estimating relations of age and education level with cognitive impairment 3 to 6 months after ischemic stroke
[1] | |
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
覃莲,黄进瑜,廖宝共,等. 缺血性脑卒中后血管性认知功能损害的临床特征及影像学研究[J]. 中国现代医学杂志,2008,18(16):2398-2401. DOI:10.3969/j.issn.1005-8982.2008.16.035.
|
[8] |
胡智艳,巩尊科,苏彩霞,等. 缺血性脑卒中患者认知功能障碍的发病率及相关因素分析[J]. 健康必读,2020(14):208,225.
|
[9] |
储新娟,涂志兰,金芃芃,等. 缺血性脑卒中患者血管性认知功能障碍的现状及影响因素分析[J]. 中国临床医生杂志,2017,45(12):43-44. DOI:10.3969/j.issn.2095-8552.2017.12.015.
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
吴纪霞,庄雷,刘洁一,等. 缺血性血管性认知障碍与血浆生化预测指标的探讨[J]. 中国实用神经疾病杂志,2018,21(2):188-192. DOI:10.12083/SYSJ.2018.02.049.
|
[30] |
庄献博,徐光军,王未飞,等. 脑梗死患者血清抗心磷脂抗体和血管内皮生长因子水平与卒中后认知障碍的关系[J]. 中华行为医学与脑科学杂志,2015,24(2):152-154. DOI:10.3760/cma.j.issn.1674-6554.2015.02.016.
|
[31] | |
[32] |
陆珍辉,李新玲,丁莉,等. 脑梗死急性期高压氧治疗对卒中后认知功能的影响[J]. 中华航海医学与高气压医学杂志,2018,25(4):244-248. DOI:10.3760/cma.j.issn.1009-6906.2018.04.008.
|
[33] |
李灵真,李山,张华. 急性脑梗死后认知功能障碍危险因素分析[J]. 宁夏医科大学学报,2011,33(1):16-19. DOI:10.3969/j.issn.1674-6309.2011.01.007.
|
[34] |
符晓艳,王羚入,马瑞雪,等. 高龄患者脑梗死后认知功能障碍相关危险因素的研究[J]. 重庆医学,2017,46(10):1394-1396. DOI:10.3969/j.issn.1671-8348.2017.10.033.
|
[35] |
李淑恩,郑伟城,林显仙,等. 脑梗死急性期低白蛋白血症与卒中后认知障碍相关性研究[J]. 中国神经精神疾病杂志,2020,46(2):75-79. DOI:10.3969/j.issn.1002-0152.2020.02.003.
|
[36] |
王延江,邓娟,李静,等. 首次卒中后认知功能损害危险因素的研究[J]. 重庆医学,2008,37(7):688-690. DOI:10.3969/j.issn.1671-8348.2008.07.007.
|
[37] |
戴一帆,黄应爽. 影响缺血性脑卒中患者认知功能预后的相关因素分析[J]. 心脑血管病防治,2012,12(3):225-257. DOI:10.3969/j.issn.1009-816X.2012.03.20.
|
[38] |
樊凡,杨翠,王庆松. 老年缺血性脑卒中患者衰弱状态与脑卒中后认知障碍的相关性研究[J]. 中华老年心脑血管病杂志,2018,20(12):1253-1257. DOI:10.3969/j.issn.1009-0126.2018.12.006.
|
[39] |
王茂松,王宏,李萌. 卒中后认知功能障碍患者血清VILIP-1水平变化及其临床意义[J]. 实用临床医学,2016,17(6):1-4. DOI:10.13764/j.cnki.lcsy.2016.06.001.
|
[40] |
陈丽英,杜江悦,胡芳,等. 老年人轻度认知障碍的综合管理[J]. 全科医学临床与教育,2020,18(2):154-156. DOI:10.13558/j.cnki.issn1672-3686.2020.002.016.
|
[41] |
袁琳丽,傅荣,李敬伟,等. 社区老年人轻度认知障碍影响因素Meta分析[J]. 现代预防医学,2019,46(22):4099-4104.
|
[42] |
|
[43] |
|
[44] |
|
[45] |
|
[46] |
|
[47] |
|
[48] |
|
[49] |
胡昔权,窦祖林,万桂芳,等. 脑卒中患者认知功能障碍的发生率及其影响因素的探讨[J]. 中华物理医学与康复杂志,2003,25(4):219-222. DOI:10.3760/j:issn:0254-1424.2003.04.009.
|
[50] |
|
[51] |
|
[52] |
|
[1] | QIN Fengyin, ZHANG Qishan, LAI Jinjia, HUANG Yimin, HAN Guoyin, SUN Xinglan, WANG Fen, TAN Yibing. Current Status and Influencing Factors of the Intention to Screen for High-risk Stroke among Community Residents in Guangdong [J]. Chinese General Practice, 2023, 26(34): 4283-4289. |
[2] | WANG Zhe, DONG Zhihao, ZHENG Hao, KONG Wencheng, ZHANG Yukuan, ZHANG Qiuyue, HAN Jing. Construction of Optimized Treatment Plan of Acupuncture for Migraine Based on Entropy Weight-TOPSIS Method [J]. Chinese General Practice, 2023, 26(34): 4336-4342. |
[3] | HAO Aihua, ZENG Weilin, LI Guanhai, XIA Yinghua, CHEN Liang. Current Situation of the Construction of Family Doctor Team: an Investigation Based on the Perspective of General Practitioners [J]. Chinese General Practice, 2023, 26(34): 4261-4268. |
[4] | LI Dianjiang, PAN Enchun, SUN Zhongming, WEN Jinbo, WANG Miaomiao, WU Ming, SHEN Chong. The Current Status and Influencing Factors of Clinical Inertia in Type 2 Diabetes Patients in Community [J]. Chinese General Practice, 2023, 26(34): 4296-4301. |
[5] | WANG Yue, CHEN Qing, LIU Lurong. Detection Rate of Depression and Its Influencing Factors in Chinese Elderly: a Meta-analysis [J]. Chinese General Practice, 2023, 26(34): 4329-4335. |
[6] | WANG Lina, GAO Pengfei, CAO Fan, GE Ying, YAN Wei, HE Daikun. Analysis of the Prevalence and Influencing Factors of Non-alcoholic Fatty Liver Disease in Different Gender Groups [J]. Chinese General Practice, 2023, 26(33): 4143-4151. |
[7] | ZHANG Jin, DING Zhiguo, QI Shuo, LI Ying, LI Weiqiang, ZHANG Yuanyuan, ZHOU Tong. Relationship between Serum Thyroid Hormone Levels and Prognosis during Hospitalization in Heart Failure Patients [J]. Chinese General Practice, 2023, 26(33): 4125-4129. |
[8] | XIN Gongkai, CONG Xin, YUAN Lei, CHENG Yuetong, NI Cuiping, ZHANG Weiwei, ZHANG Pingping, LIU Yu. Research Progress on Comprehensive Assessment Tools for the Elderly with Dementia [J]. Chinese General Practice, 2023, 26(33): 4103-4109. |
[9] | ZHOU Yuyu, GAO Chuan, CUI Puan, WANG Yaping, HE Zhong. Influencing Factors of Shared Decision Making between Doctors and Patients in Menopausal Hormone Therapy in Patients with Menopausal Syndrome [J]. Chinese General Practice, 2023, 26(33): 4181-4186. |
[10] | SU Kaiqi, LYU Zhuan, WU Mingli, LUO Meng, GAO Jing, NIE Chenchen, LIU Hao, FENG Xiaodong. Effect of Electroacupuncture on BDNF/TrkB/PI3K/Akt Pathway and Hippocampal Neuronal Protection in Rats with Learning and Memory Impairment after Ischemia Reperfusion [J]. Chinese General Practice, 2023, 26(33): 4187-4193. |
[11] | YIN Miaomiao, CUI Liling, LI Yaqing, WANG Liqun, ZHANG Yue, WU Jialing. Effect of Dual Task on Walking Ability in Posterior Circulation Ischemic Stroke Patients with Vestibular Symptoms [J]. Chinese General Practice, 2023, 26(33): 4207-4212. |
[12] | LIANG Xuan, NA Feiyang, QIN Mengyao, YANG Hui, GUO Li, GUO Qi, REN Lei, CHEN De, LIU Donghai, ZHANG Rongfang. Clinical Characteristics and Influencing Factors of Bronchial Asthma Combined with Obstructive Sleep Apnea-hypopnea Syndrome in Children [J]. Chinese General Practice, 2023, 26(33): 4225-4230. |
[13] | LI Qianqian, CHEN Xunrui, ZHANG Wenying, YUAN Haihua, ZHANG Yanjie, JIANG Bin, LIU Feng. Demand and Influencing Factors for Community Health Services during Chemotherapy of Patients with Advanced Cancer [J]. Chinese General Practice, 2023, 26(33): 4173-4180. |
[14] | GAO Dekang, WEI Shaohua, MA Xiaoming, DU Peng, XING Chungen, CAO Chun. Risk Factors for Loss of Skeletal Muscle Mass and Its Correlation with Complications after Major Hepatectomy for Liver Cancer [J]. Chinese General Practice, 2023, 26(32): 4031-4037. |
[15] | YANG Yuxuan, ZHANG Han, DU Juan, WANG Lingling, XIE Yulei, YIN Kaiming, ZHANG Bo. Value of an Dynamic Eye-tracking Task in Assessing Unilateral Spatial Neglect after Stroke [J]. Chinese General Practice, 2023, 26(32): 4020-4025. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||